Innovations in cancer treatment enable therapies to be tailored to each person’s individual characteristics or symptoms, and how that person responds to treatment during all stages of care. This could potentially mean that patients can live longer and better lives with cancer. But such cutting-edge care comes at a steep price, and can Malaysians afford it? Dr Matin Mellor, Consultant Clinical Oncologist; and Professor Adrian Towse, Director Emeritus, Office of Health Economics, UK, share how Malaysia can use innovative financing approaches to expand access to precision medicine.

Image Source: Shutterstock